We hope you enjoyed your first year of NPP membership. More than 300,000 NPP members save on items they use every day from Verizon, Staples, Priceline, Sherwin-Williams, Airgas and more.
Your purchases make a difference. NPP is owned by non-profit hospitals and a substantial portion of our proceeds help support medical research at Benaroya Research Institute at Virginia Mason (BRI) in Seattle, WA. BRI works to predict, prevent and cure immune system diseases such as multiple sclerosis, type 1 diabetes, food allergies and Crohn’s disease.
Happy Anniversary! Save money. Save lives.
Breakthrough Delays T1D
Benaroya Research Institute at Virginia Mason (BRI) is involved in a clinical study of a drug called teplizumab that could slow down type 1 diabetes. A recent breakthrough showed that teplizumab delayed T1D for a median of two years for those at high risk for the disease. Learn more about BRI efforts to predict, prevent and cure T1D.
Peanut Allergy Progress
Eric Wambre, PhD leads lab research of allergies at BRI. A current focus is peanut allergies which have grown more common in recent years. Dr. Wambre identified a cell called TH2A that appears to cause all allergies. “We’re exploring how drugs can block TH2A cells and maybe stop allergies altogether,” says Dr. Wambre.